Pixelgen Technologies
Sweden-based provider of a platform for new applications in cell-to-cell interactions and tissue
Pixelgen Technologies has raised €26M across 2 funding rounds from 4 investors, most recently a Series B round in Aug 2026. Based in Stockholm, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Stockholm, Swedenwww.pixelgen.com ↗
Total raised
€26M
€25,716,491
Funding rounds
2
Investors
4
distinct backers
Active since
2025-07
latest 2026-08
Funding by year
EUR raised per year · 2026 YTDPixelgen Technologies — funding by year — interactive chart.
Data table
| Pixelgen Technologies — funding by year | |
|---|---|
| 2025 | €12M |
| 2026 | €13M |
Signals
High confidenceRaise-next likelihood22
base rate 48% for Series B
- ▼ Raised very recently
- ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
- ▼ Young (<3y)
- ▲ Recently backed by strong-exit-track investors
Timing: too soon vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-08-20 | Series B | €13M | Flat Capital,Industrifonden,Navigare Ventures | View deal → |
| 2025-07-01 | Other | €12M | European Innovation Council (EIC) Accelerator | View deal → |